ERBB2 and neoplasm: Whereas treatment with C-6 resulted in EC50 values in the range of 20 to 30 μM in both the ER+ and triple negative PEs, the HER2+ tumor exhibited a higher EC50 of 75.7 μM, which may suggest some resistance in HER2+ tumors.